2
Views
1
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Transdermal nitroglycerin for preterm labor

&
Pages 417-421 | Published online: 10 Jan 2014

References

  • Di Renzo GC, Roura LC; European Association of Perinatal Medicine Study Group on Preterm Birth. Guidelines for the management of spontaneous preterm labor. J. Perinat. Med.34(5), 359–366 (2006).
  • Blondel B, Macfarlane A, Gissler M, Breart G, Zeitlin J; PERISTAT Study Group. Preterm birth and multiple pregnancy in European countries participating in the PERISTAT project. Br. J. Obstet. Gynaecol.113(5), 528–535 (2006).
  • The Canadian Preterm Labor Investigators Group. Treatment of preterm labor with the β-adrenergic agonist ritodrine. N. Engl. J. Med.327(5), 308–312 (1992).
  • Leveno KJ, Cunningham FG. β-adrenergic agonists for preterm labor. N. Engl. J. Med.327(5), 349–351 (1992).
  • Lamont RF. The pathophysiology of pulmonary oedema with the use of β-agonists. Br. J. Obstet. Gynaecol.107(4), 439–444 (2000).
  • Crowther CA, Moore V. Magnesium for preventing preterm birth after threatened preterm labour. Cochrane Database Syst. Rev. (2), CD000940 (2001).
  • Royal College of Obstetricians and Gynecologists. Clinical Green Top Guidelines. Tocolytic Drugs for Women in Preterm Labour (1B). RCOG, London, UK (2002).
  • Moutquin JM, Sherman D, Cohen H et al. Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study. Am. J. Obstet. Gynecol.182(5), 1191–1199 (2000).
  • Schmitz T, Cabrol D. Tocolysis. Atosiban, an ocytcin-receptor antagonist. J. Gynecol. Obstet. Biol. Reprod. (Paris)30(3), 238–245 (2001).
  • Lamont RF, Khan KS, Beattie B et al; Steering Group of the International Preterm Labour Council. The quality of nifedipine studies used to assess tocolytic efficacy: a systematic review. J. Perinat. Med.33(4), 287–295 (2005).
  • Van Geijn HP, Lenglet JE, Bolte AC. Nifedipine trials: effectiveness and safety aspects. Br. J. Obstet. Gynaecol.112(Suppl. 1), 79–83 (2005).
  • Lees C, Campbell S, Jauniaux E et al. Arrest of preterm labour and prolongation of gestation with glyceryl trinitrate, a nitric oxide donor. Lancet343(8909), 1325–1326 (1994).
  • Lees CC, Lojacono A, Thompson C et al. Glyceryl trinitrate and ritodrine in tocolysis: an international multicenter randomized study. GTN Preterm Labour Investigation Group. Obstet. Gynecol.94(3), 403–408 (1999).
  • Smith GN, Walker MC, McGrath MJ. Randomised, double-blind, placebo controlled pilot study assessing nitroglycerin as a tocolytic. Br. J. Obstet. Gynaecol.106(7), 736–739 (1999).
  • Jennings RW, MacGillivray TE, Harrison MR. Nitric oxide inhibits preterm labour in Rhesus monkeys. J. Maternal Fetal Med.2, 170–175 (1993).
  • Smith GN, Brien JF. Use of nitroglycerin for uterine relaxation. Obstet. Gynecol. Surv.53(9), 559–565 (1998).
  • Smith GN, Walker MC, Ohlsson A, O’Brien K, Windrim R; Canadian Preterm Labour Nitroglycerin Trial Group. Randomized double-blind placebo-controlled trial of transdermal nitroglycerin for preterm labor. Am. J. Obstet. Gynecol.196(1), 37.e1–37.e8 (2007).
  • Neri I, Di Renzo GC, Caserta G, Gallinelli A, Facchinetti F. Impact of the l-arginine/nitric oxide system in pregnancy. Obstet. Gynecol. Surv.50, 851–858 (1995).
  • De Pace V, Chiossi G, Facchinetti F. Clinical use of nitric oxide donors and l-arginine in obstetrics. J. Mat. Fet. Neonat. Med. (2007) (In press).
  • Pagliaro P. Differential biological effects of products of nitric oxide (NO) synthase: it is not enough to say NO. Life Sci.73, 2137–2149 (2003).
  • Rowlands S, Trudinger B, Visva-Lingam S. Treatment of preterm cervical dilatation with glyceryl trinitrate, a nitric oxide donor. Aust. NZ J. Obstet. Gynaecol.36, 377–381 (1996).
  • Haghighi L, Akbarian A. Isosorbide dinitrate for treatment of preterm labor. Int. J. Gynaecol. Obstet.89, 274–275 (2005).
  • Duckitt K, Thornton S. Nitric oxide donors for the treatment of preterm labor. Cochrane Database Syst. Rev. (3), CD002860 (2002).
  • Buhimschi CS, Buhimschi IA, Malinow AM, Weiner CP. Effects of sublingual nitroglycerin on human uterine contractility during the active phase of labor. Am. J. Obstet. Gynecol.187, 235–238 (2002).
  • Berghella V, Ness A, Bega G, Berghella A. Cervical sonography in women with symptoms of preterm labour. Obstet. Gynecol. Clin. North Am.32, 383–396 (2005).
  • Honest H, Bachmann LM, Sundaram R, Gupta JK, Kleijnen J, Khan KS. The accuracy of risk scores in predicting preterm birth – a systematic review. Br. J. Obstet. Gynaecol.24(4), 343–359 (2004).
  • Meis PJ, Klebanoff M, Thom E et al; National Institute of Child Health and Human Development Maternal–Fetal Medicine Units Network. Prevention of recurrent preterm delivery by 17 α-hydroxyprogesterone caproate. N. Engl. J. Med.348(24), 2379–2385 (2003). Erratum in: N. Engl. J. Med.349(13), 1299 (2003).
  • Da Fonseca EB, Bittar RE, Carvalho MH, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am. J. Obstet. Gynecol.188, 419–424 (2003).
  • Facchinetti F, Paganelli S, Comitini G, Dante G, Volpe A. Cervical length changes during preterm cervical ripening: effects of 17α-hydroxy-progesterone caproate. Am. J. Obstet. Gynecol.196(5), 453.e1–453.e4 (2007).
  • James MA, Papouchado M, Jones JV. Attenuation of nitrate effect during an intermittent treatment regimen and the time course of nitrate tolerance. Eur. Heart J.12(12), 1266–1272 (1991).
  • Kim D, Rybalkin SD, Pi X et al. Upregulation of phosphodiesterase 1A1 expression is associated with the development of nitrate tolerance. Circulation104(19), 2338–2343 (2001).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.